BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 7, 2010
View Archived Issues
ARQ-621 well tolerated to date in phase I study
Read More
Emory University claims novel HSP 90 inhibitors
Read More
Argenta Discovery claims novel CRTH2 receptor antagonists
Read More
Novel activators of hyaluronan transport disclosed by German scientists
Read More
Amira Pharmaceuticals describes novel DP2 receptor antagonists
Read More
Novel p38alpha MAPK inhibitors identified by Amgen
Read More
Dual VEGFR-2/HGFR inhibitor ASP-08126 shows promising preclinical potential
Read More
Multiplex PI3K inhibitors suppress Ras-mutated tumors in vitro and in vivo
Read More
Rivastigmine patch improves hepatic encephalopathy in clinical trial
Read More
New biomarkers of end-stage renal disease identified
Read More
Scancell obtains approval to conduct trial for SCIB-1 melanoma vaccine
Read More
Ariad and MSD restructure collaboration for ridaforolimus in oncology
Read More
Bayer Schering and EndoCeutics form global agreement for intravaginal DHEA
Read More
FDA clearance for Aradigm's inhaled liposomal ciprofloxacin trial in CF pediatric patients
Read More
BELLUS discontinues NC-503 development for diabetes following proof-of-concept study
Read More
Ralfinamide does not meet primary endpoint in topline results from Newron's SERENA trial
Read More
Novo Nordisk to begin phase III cardiovascular outcomes trial for Victoza in fall 2010
Read More
Keryx initiates phase III registration program for Zerenex
Read More
Boehringer Ingelheim and Micromet collaborate for multiple myeloma antibody
Read More
Eisai seeks approval in Japan for twice-daily dosing of Pariet for reflux esophagitis
Read More
Novocell changes name to ViaCyte
Read More
Synergistic tolerogenic effects seen with RGI-2001 and anti-thymocyte globulin in vivo
Read More
FDA review sets new PDUFA action date for Bydureon
Read More
Acceleron initiates phase II ACE-031 trial in Duchenne muscular dystrophy
Read More
CNTO-2476 well tolerated in first-in-human study in patients with retinitis pigmentosa
Read More
Sinovac submits application to begin clinical trials for mumps vaccine in China
Read More
Bayer receives FDA approval for Natazia for prevention of pregnancy
Read More